link to RWJMS home page
shadow

Research

Publications

Staff members at the division of Clinical Pharmacology have published numerous articles in a variety of journals and publications. Below is a listing of some of these works:

  • Malaviya R, Sun Y, Tan JK, Magliocco M, Gottlieb AB: Induction of lesional and circulating leucocyte apoptosis by infliximab in a patient with moderate to severe psoriasis. J Drugs Dermatol 5(9):890-3, 2006.
  • Malaviya R, Sun Y, Tan JK, Wang A, Magliocco M, Yao M, Kreuger JG, Gottlieb AB: Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients. 55(4):590-7, 2006.
  • Magliocco MA, Pandya K, Dombrovskiy V, Christiansen L, Wong Y, Gottlieb AB: A randomized, double-blind, vehicle-controlled, bilateral comparison trial of bexarotene gel 1% versus vehicle gel in combination with narrowband UVB phototherapy for moderate to sever psoriasis vulgaris. J Am Acad Dermatol 54(1):115-8, 2006.
  • Myers W, Newman M, Katz B, Gottlieb AB: Ability to develop rhus allergic reaction contact dermatitis in a patient with psoriasis receiving etanercept. J Am Acad Dermatol 55(5 Suppl):S127-8, 2006.
  • Myers WA, Gottlieb AB, Mease P: Psoriasis and psoriatic arthritis: clinical features and disease mechanisms. ClinDermatol 24(5):438-47, 2006.
  • Myers W, Tan J, and Gottlieb AB: Combination Therapy in Koo J, Lebwohl M, and Lee C, eds. Mild to Moderate Psoriasis, Informa Healthcare USA, Inc. New York, 2006, pp 147-162.
  • Gottlieb AB, Chamian F, Masud S, Cardinale I, Abello MV, Lowes MA, Chen F, Magliooco M, Kreuger JG: TNF inhibition rapidly down-regulates multiple proinflammatroy pathways in psoriasis plaques. J Immunol 175(4):2721-9, 2005.
  • Magliocco MA: Emerging drugs for moderate-to-severe psoriasis. Expert Opin Emerg Drugs 10(1):35-52, 2005.
    Kipnis CD, Myers WA, Opeola M, Gottlieb AB: Biologic Treatments for Psoriasis. J.Amer.Acad.Dermatol. 52: 671-682, 2005.
  • Myers W, Christiansen L, Gottlieb AB: Treatment of palmoplantar psoriasis with intramuscular alefacept. J AM Acad Dermatol 53(2 Suppl 1):S127-30, 2005.
  • Magliocco MA, Gottlieb AB: Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. J Am Acad Dermatol 51(4): 580-4, 2004
  • Myers W, Opeola M, Gottlieb AB : Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis. Current Rheumatology Reports 6:306-313, 2004.
  • Leighton A, Gottlieb AB, Dorr MB, Jabes D, Mosconi G, VanSaders C, Mroszczak EJ, Campbell KCM, Kelly E: Tolerability, pharmacokinetics and serum bactericidal activity of intravenous dalbavancin in healthy volunteers. Antimicrobial Agents and Chemotherapy 48: 940-945, 2004.